Pilot Trial of Supplemental Vitamin A and Nicotinamide

Summary

The goal of this clinical trial is to assess the feasibility and safety of oral nicotinamide (NAM; a derivative of vitamin B3 \[niacin\]) and vitamin A in a high-risk population of kidney transplant recipients with a history of skin cancer to generate preliminary data for future cancer prevention clinical trials.

Timeline

Start

2023-04-01

Primary completion

2028-01-01

Completion

2028-03-01

Drugs

Indications